Akebia Therapeutics, Inc. (AKBA)

NASDAQ: AKBA · Real-Time Price · USD

1.180

0.00 (0.00%)

At close: May 13, 2026, 4:00 PM EDT

1.187

+0.007 (0.55%)

After-hours: May 13, 2026, 4:16 PM EDT

Akebia Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	317	427	427	241	106	400
Market Cap Growth	-44.85%	0.03%	77.06%	127.10%	-73.44%	-3.52%
Enterprise Value	350.08	290.74	417.58	224.49	78.82	283.93
Last Close Price	1.18	1.61	1.90	1.24	0.58	2.26
PE Ratio	-	-80.50	-5.76	-4.43	-1.11	-1.33
Forward PE	-	82.56	-	-	-	-
PS Ratio	1.36	1.81	2.67	1.24	0.36	1.89
PB Ratio	11.55	13.10	-8.69	-7.89	20.31	5.41
P/TBV Ratio	11.62	12.70	-8.15	-7.60	20.17	5.07
P/FCF Ratio	5.25	6.31	-10.50	-10.32	-1.45	-1.58
P/OCF Ratio	5.22	6.29	-10.51	-10.32	-1.45	-1.58
EV/Sales Ratio	1.51	1.23	2.61	1.15	0.27	1.34
EV/EBITDA Ratio	28.86	11.74	-32.20	-26.02	-1.83	-1.25
EV/EBIT Ratio	32.27	12.37	-8.27	-4.85	-0.98	-1.07
EV/FCF Ratio	5.83	4.29	-10.26	-9.60	-1.08	-1.12
Debt / Equity Ratio	1.33	1.48	-0.86	-0.85	12.05	0.46
Debt / EBITDA Ratio	7.44	1.95	-3.26	-5.06	-2.21	-0.58
Debt / FCF Ratio	0.81	0.71	-1.04	-1.87	-1.30	-0.52
Net Debt / Equity Ratio	-4.15	-4.19	0.20	-0.02	0.87	-0.25
Net Debt / EBITDA Ratio	-17.31	-5.51	0.74	-0.08	-0.11	0.08
Net Debt / FCF Ratio	-1.89	-2.02	0.24	-0.03	-0.06	0.07
Asset Turnover	0.63	0.79	0.69	0.65	0.66	0.36
Inventory Turnover	3.09	2.48	3.96	3.98	2.94	3.09
Quick Ratio	1.30	1.42	1.07	0.82	1.01	0.77
Current Ratio	1.40	1.55	1.41	1.18	1.43	1.04
Return on Equity (ROE)	-68.39%	64.49%	174.03%	409.60%	-237.83%	-175.37%
Return on Assets (ROA)	1.56%	11.30%	-21.83%	-15.48%	-18.25%	-45.08%
Return on Invested Capital (ROIC)	10.03%	48.58%	-48.87%	-32.10%	-39.53%	-120.10%
Return on Capital Employed (ROCE)	2.63%	13.30%	-35.85%	-25.12%	-32.65%	-72.94%
Earnings Yield	-6.51%	-1.24%	-17.37%	-22.58%	-90.12%	-75.22%
FCF Yield	19.05%	15.84%	-9.52%	-9.69%	-68.96%	-63.25%
Buyback Yield / Dilution	-21.26%	-21.91%	-12.53%	-2.56%	-10.14%	-19.85%
Total Shareholder Return	-21.26%	-21.91%	-12.53%	-2.56%	-10.14%	-19.85%

Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q